David Naemura
Analyst · JPMorgan. Your line is now open
Thanks, Mark. Adjusted net earnings for the fourth quarter were $141 million, a decrease of 4% from $147 million in the prior-year period. This translated to adjusted net earnings per share of $0.83. The decrease in earnings was driven by lower sales conversion as a result of the ongoing supply chain constraints and component shortages. Our strong price actions and better-than-expected bottom-line results from our acquisition of DRB partially offset the EMV and ongoing inflation headwinds during the quarter. Reported growth declined 3% and core revenue declined approximately 8% in the fourth quarter due to the expected decline of EMV, as well as the tough comparison to the strong recovery that we experienced in Q4 of 2020 which included not only a high point in quarterly shipments of EMV, but also benefited from the Mexico regulatory driver and overall high single-digit growth in our non-EMV revenues. On an [Indiscernible] basis, reported revenue grew high single-digits, and core revenue was about flat despite the otherwise difficult comparison. Adjusted operating profit for the fourth-quarter was $194 million, a decrease of 3% compared to the prior year period, primarily driven by the lower revenue volumes, which was partially [Indiscernible] that by a 140 basis points of adjusted gross margin expansion, largely resulting from the accretive addition of DRB. Adjusted core operating margin for the quarter decreased 70 basis points reflecting the impact of the core revenue decline. Adjusted operating margin was in line with the prior year at 24.6%. We continued to effectively offset the impact of raw material inflation with price actions, which was about net margin in the quarter. We did see some margin headwind per mix due to the size of the EMV decline and this was offset by the positive impact of DRB on our operating margin. In the fourth quarter, we generated adjusted free cash flow of a $148 million, a conversion of 105%, reflecting a slight decrease in working capital during the quarter. Working capital dollars at the end of Q4 were 6.1% of the last 12 months sales, an increase from 5.6% low point in Q1, but still very low historically. Our full year adjusted free cash flow conversion was 96%, which included the additional tax payment in Q2. Shifting to liquidity, we ended the quarter with a cash balance of $573 million, and had no borrowings under our $750 million credit facility. Our net leverage stands at 2.8 times adjusted EBITDA at the end of 2021. As Mark noted, we anticipate the deployment of some capital towards share repurchase as market conditions warrant and we will continue to assess this opportunity. Looking at the performance of our two platforms, eMobility Technology's core revenue declined 11%, which reflects a low double-digit decline in core revenue at TBR. Growth in environmental and services was more than offset by the decline in EMV, as well as lower sales conversion in both developed and high-growth markets given the impact from supply chain constraints and COVID. After including the revenue contribution from DRB, the mobility technologies, total revenue declined 4.5 [Indiscernible] Q5 was our first full quarter -- Q4 was our first full quarter with DRB in the portfolio. And we could not be more happy with the momentum and performance they have exhibited. DRB delivered high teens sales growth, primarily driven by double digit growth in point-of-sale control systems. Core revenue growth in our Diagnostics and Repair Technologies platform was 2% driven by low single-digit growth at Matco, reflecting the continued strong demand environment against the recovery compare from the prior year partially offset by a supply and labor-constrained environment across the platform. Diagnostics and repair bookings grew at a mid-single-digit rate, demonstrating the continued demand backdrop and also the challenges of sales conversion. Matco demonstrated a strong year of net new franchisee additions which will be additive to the expected solid growth from same-store sales in 2022. Looking at total company sales regionally, the EMV and other compared dynamics read through quite clearly. Developed markets core revenue declined mid-single-digits as a result of the EMV impact in North America. In our high-growth markets, we declined about 20% compared to the mid-teen’s growth in the prior-year Q4, reflecting not only the challenging comparison, but also supply chain and COVID impacts sales conversion. High-growth markets will of course, remain lumpy, but we remain confident in areas such as India, Middle East, and Africa, and Latin America as long-term opportunities for outsized growth given future regulatory drivers, investment in fueling infrastructure and our physical presence in these strategically important markets. We remain committed to our profit improvement actions that will better position the company in 2022 and beyond. During the fourth quarter, we recognized restructuring charges of approximately 4 million, slightly lower than we previously planned as the timing of certain actions have now shifted into 2022. We now anticipate we will recognize 2022 charges of about $15 million, which is a continuation of post-spin actions to drive simplification globally and to align resources with our highest priority future growth opportunities. We continue to expect we will achieve our original savings objectives for 2022 from 2021 [Indiscernible]. Turning to the outlook assumptions for the full year 2022, we expect core revenue growth of low to mid-single-digits, which includes an expected EMV headwind, $25 million to $50 million. Our price actions have largely been priced into our backlog and so we expect to be price-cost positive in 2022. Our core operating margin expansion target is 30 to 60 basis points, reflecting continued execution on our profitable growth initiatives and cost management, partially offset by persistent inflationary pressures, supply chain and logistics constraints, [Indiscernible]. That said, we are establishing our full year outlook for adjusted earnings per share at a range of $3.05 to $3.15, reflecting continued momentum and execution in our core business as well as an expected high teen cents contribution from the full year impact of the DRB acquisition, partially offset by some dilution from drives in the high single-digit cents per share range. We anticipate our full year effective tax rate to be around 23% as we capture the benefits from our ongoing tax planning initiatives. We enjoy a CAPEX light business model with capital expenditures in 2021 of $48 million or about 1.6% of sales, and we expect CAPEX of about 1.5% of sales in 2022. As for free cash flow conversion after seen working capital increase. In the second and third quarters of 2021, working capital decreased to very low levels again in the fourth quarter. While we anticipate some normalization of working capital levels in 2022, we expect free cash flow conversion for the full year of 2022 to be approximately 100%. Moving on to the first quarter of 2022, we expect core revenue will be a decline of low single-digits to flat, as mid-single-digits core growth in our non-EMV businesses only partially offset to the ongoing sales conversion headwinds and reflects the difficult Mexico compare and the continued tough comp on EMV, which was strong in '21 ahead of the adoption deadline, adjusted core operating margin is expected to be flat, reflecting our continued execution and supply constrained environment. As Mark stated, this translates into a [Indiscernible] per share of 64 to $0.67 in the quarter. With that, I'll turn it back to Mark.